Furthermore, to reduce the risk of including patients with non-ATTR amyloidosis, particularly light-chain amyloidosis (the other most common cause of grade 1 cardiac uptake), we limited inclusion to patients without PCD or required histologic confirmation of ATTR amyloid in those with PCD. Here, TTR is linked to AL amyloidosis.